Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001595585-21-000130
Filing Date
2021-11-17
Accepted
2021-11-17 16:26:10
Documents
1
Period of Report
2021-11-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_163718435023406.html 4  
1 FORM 4 wf-form4_163718435023406.xml 4 9328
  Complete submission text file 0001595585-21-000130.txt   10724
Mailing Address C/O ORBIMED ADVISORS LLC 601 LEXINGTON AVENUE, 54TH FLOOR NEW YORK NY 10022
Business Address
Bonita David P (Reporting) CIK: 0001572451 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38558 | Film No.: 211420891

Mailing Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080 415-429-7800
Tricida, Inc. (Issuer) CIK: 0001595585 (see all company filings)

EIN.: 463372526 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations